Kite Pharma, Inc. Operating Margin
- Operating margin · 12 months: Value -1102.50%; Formula and calculation Operating income / revenue. Period ending 2017-06-30..
Operating margin
Overview →Financial period ending 2017-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -1102.50% | Operating income / revenue. Period ending 2017-06-30. $-354.30M ÷ $32.14M × 100 ≈ -1102.50% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -354.30M USD | Operating Income (Loss) |
| Revenue | 32.14M USD | |
| Cost of products and services | (m) | |
| Research and development | 252.94M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2017-06-30 | $-354.30M | $32.14M | (m) | $252.94M | (m) | -1102.50% |
| 2017-03-31 | $-319.13M | $26.88M | (m) | $229.43M | (m) | -1187.28% |
| 2016-12-31 | $-273.19M | $22.17M | (m) | $197.93M | (m) | -1232.24% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $-178.68M | $19.90M | (m) | $132.29M | (m) | -898.09% |
| 2016-03-31 | $-134.30M | $19.50M | (m) | $101.52M | (m) | -688.60% |
| 2015-12-31 | $-103.95M | $17.26M | (m) | $76.37M | (m) | -602.33% |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $-49.11M | (m) | (m) | $30.26M | (m) | (m) |
| 2014-12-31 | $-36.66M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $-8.50M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-6.43M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-2.58M | (m) | (m) | $1.81M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.